Insights into Anti-metastatic therapy: Tumor suppressor AML2 suppresses the expression of PIK3CD [Phosphoinositide-3-kinase catalytic subunit-δ] via up regulation of its target gene, 12/February/2014, 7.13 am

Insights into the regulation of Cell cycle & Chemosensitivity: Tumor suppressor p53 suppresses the expression of cyclin dependent kinase 6 (CDK6) via up regulation of its target gene, 12/February/2014, 7.08 am
February 12, 2014
Molecular cancer therapy: Celastrol, an antioxidant & anti-inflammatory drug, increases the tumor suppressor KRIT1/CCM1 expression via down regulation of its target gene , 12/February/2014, 7.19 am
February 12, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into Anti-metastatic therapy: Tumor suppressor AML2 suppresses the expression of PIK3CD [Phosphoinositide-3-kinase catalytic subunit-δ] via up regulation of its target gene 12/February/2014, 7.13 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.